BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15001689)

  • 1. Dynamic imaging of striatal D2 receptors in mice using quad-HIDAC PET.
    Honer M; Brühlmeier M; Missimer J; Schubiger AP; Ametamey SM
    J Nucl Med; 2004 Mar; 45(3):464-70. PubMed ID: 15001689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of scatter correction on the compartmental measurement of striatal and extrastriatal dopamine D2 receptors using [123I]epidepride SPET.
    Fujita M; Varrone A; Kim KM; Watabe H; Zoghbi SS; Seneca N; Tipre D; Seibyl JP; Innis RB; Iida H
    Eur J Nucl Med Mol Imaging; 2004 May; 31(5):644-54. PubMed ID: 14730406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Within-subject comparison of striatal D2 receptor occupancy measurements using [123I]IBZM SPECT and [11C]Raclopride PET.
    Catafau AM; Suarez M; Bullich S; Llop J; Nucci G; Gunn RN; Brittain C; Laruelle M;
    Neuroimage; 2009 Jun; 46(2):447-58. PubMed ID: 19233294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic analyses of [123I]IBZM SPECT for quantification of striatal dopamine D2 receptor binding: a critical evaluation of the single-scan approach.
    Meyer PT; Sattler B; Winz OH; Fundke R; Oehlwein C; Kendziorra K; Hesse S; Schaefer WM; Sabri O
    Neuroimage; 2008 Aug; 42(2):548-58. PubMed ID: 18595739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [18F]Fallypride PET measurement of striatal and extrastriatal dopamine D 2/3 receptor availability in recently abstinent alcoholics.
    Rominger A; Cumming P; Xiong G; Koller G; Böning G; Wulff M; Zwergal A; Förster S; Reilhac A; Munk O; Soyka M; Wängler B; Bartenstein P; la Fougère C; Pogarell O
    Addict Biol; 2012 Mar; 17(2):490-503. PubMed ID: 22023291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of D2-like dopamine receptors in the human brain with 18F-desmethoxyfallypride.
    Gründer G; Siessmeier T; Piel M; Vernaleken I; Buchholz HG; Zhou Y; Hiemke C; Wong DF; Rösch F; Bartenstein P
    J Nucl Med; 2003 Jan; 44(1):109-16. PubMed ID: 12515884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain imaging of 18F-fallypride in normal volunteers: blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors.
    Mukherjee J; Christian BT; Dunigan KA; Shi B; Narayanan TK; Satter M; Mantil J
    Synapse; 2002 Dec; 46(3):170-88. PubMed ID: 12325044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary assessment of extrastriatal dopamine D-2 receptor binding in the rodent and nonhuman primate brains using the high affinity radioligand, 18F-fallypride.
    Mukherjee J; Yang ZY; Brown T; Lew R; Wernick M; Ouyang X; Yasillo N; Chen CT; Mintzer R; Cooper M
    Nucl Med Biol; 1999 Jul; 26(5):519-27. PubMed ID: 10473190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of striatal and extrastriatal D-2 dopamine receptors using PET imaging of [(18)F]fallypride in nonhuman primates.
    Christian BT; Narayanan TK; Shi B; Mukherjee J
    Synapse; 2000 Oct; 38(1):71-9. PubMed ID: 10941142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occupancy of dopamine D2 receptors in the mouse brain measured using ultra-high-resolution single-photon emission tomography and [123]IBF.
    Acton PD; Hou C; Kung MP; Plössl K; Keeney CL; Kung HF
    Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1507-15. PubMed ID: 12537007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parametric mapping of binding in human brain of D2 receptor ligands of different affinities.
    Siessmeier T; Zhou Y; Buchholz HG; Landvogt C; Vernaleken I; Piel M; Schirrmacher R; Rösch F; Schreckenberger M; Wong DF; Cumming P; Gründer G; Bartenstein P
    J Nucl Med; 2005 Jun; 46(6):964-72. PubMed ID: 15937307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiolabeling and in vitro and in vivo evaluation of [18F]-FE-DABP688 as a PET radioligand for the metabotropic glutamate receptor subtype 5.
    Honer M; Stoffel A; Kessler LJ; Schubiger PA; Ametamey SM
    Nucl Med Biol; 2007 Nov; 34(8):973-80. PubMed ID: 17998101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (-)-N-[(11)C]propyl-norapomorphine: a positron-labeled dopamine agonist for PET imaging of D(2) receptors.
    Hwang DR; Kegeles LS; Laruelle M
    Nucl Med Biol; 2000 Aug; 27(6):533-9. PubMed ID: 11056366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of [18F]FDOPA, [18F]FMT and [18F]FECNT for imaging dopaminergic neurotransmission in mice.
    Honer M; Hengerer B; Blagoev M; Hintermann S; Waldmeier P; Schubiger PA; Ametamey SM
    Nucl Med Biol; 2006 Jul; 33(5):607-14. PubMed ID: 16843835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitation of carbon-11-labeled raclopride in rat striatum using positron emission tomography.
    Hume SP; Myers R; Bloomfield PM; Opacka-Juffry J; Cremer JE; Ahier RG; Luthra SK; Brooks DJ; Lammertsma AA
    Synapse; 1992 Sep; 12(1):47-54. PubMed ID: 1411963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of intravenous and intraperitoneal [123I]IBZM injection for dopamine D2 receptor imaging in mice.
    Meyer PT; Salber D; Schiefer J; Cremer M; Schaefer WM; Kosinski CM; Langen KJ
    Nucl Med Biol; 2008 Jul; 35(5):543-8. PubMed ID: 18589298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo measurement of D2 receptor density and affinity for 18F-(3-N-methyl)benperidol in the rat striatum with a PET system for small laboratory animals.
    Nikolaus S; Larisch R; Beu M; Hamacher K; Forutan F; Vosberg H; Müller HW
    J Nucl Med; 2003 Apr; 44(4):618-24. PubMed ID: 12679408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous competition against binding of [(18)F]DMFP and [(18)F]fallypride to dopamine D(2/3) receptors in brain of living mouse.
    Rominger A; Wagner E; Mille E; Böning G; Esmaeilzadeh M; Wängler B; Gildehaus FJ; Nowak S; Bruche A; Tatsch K; Bartenstein P; Cumming P
    Synapse; 2010 Apr; 64(4):313-22. PubMed ID: 19957365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of extrastriatal dopamine D2 receptor density and affinity in the human brain using PET.
    Olsson H; Halldin C; Farde L
    Neuroimage; 2004 Jun; 22(2):794-803. PubMed ID: 15193608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring dopamine neuromodulation in the thalamus: using [F-18]fallypride PET to study dopamine release during a spatial attention task.
    Christian BT; Lehrer DS; Shi B; Narayanan TK; Strohmeyer PS; Buchsbaum MS; Mantil JC
    Neuroimage; 2006 May; 31(1):139-52. PubMed ID: 16469510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.